tiprankstipranks
Trending News
More News >

YiChang HEC ChangJiang Pharmaceutical Announces Shareholders’ Meeting for Merger Approval

Story Highlights
YiChang HEC ChangJiang Pharmaceutical Announces Shareholders’ Meeting for Merger Approval

Don’t Miss TipRanks’ Half-Year Sale

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has shared an announcement.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced an H shareholders’ class meeting scheduled for July 21, 2025, to consider a special resolution regarding a merger agreement with Sunshine Lake Pharma Co., Ltd. The approval of this merger is contingent on a 75% affirmative vote from independent H shareholders, with less than 10% opposition. This meeting is crucial for the company’s strategic direction and could significantly impact its market position and stakeholder interests.

The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.

More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company incorporated in the People’s Republic of China, focusing on the development, production, and sale of pharmaceutical products.

Average Trading Volume: 9,690,048

Technical Sentiment Signal: Buy

Current Market Cap: HK$13.11B

For an in-depth examination of 1558 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1